Stock Appreciation Rights (SARs)
Stock Appreciation Rights (SARs) [Member]
Schedule of Accrued Liabilities
Schedule of Accrued Liabilities [Table Text Block]
Accrued liabilities
Total accrued liabilities
Accrued Liabilities, Current
Other non-current liabilities
Other Noncurrent Liabilities [Member]
Line of credit, maximum borrowing capacity
Line of Credit Facility, Maximum Borrowing Capacity
Proposed additional tax including interest and penalties
Income Tax Examination, Estimate of Possible Loss
Changes in assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Grants expiration period (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Award Type [Domain]
Award Type [Domain]
Fair Value as of Grant Date
Award Grant Date Fair Value
Acquired in-process research and development
Acquired in-process research and development
Research and Development Asset Acquired Other than Through Business Combination, Writeoff
Total lease liabilities
Operating And Finance Lease, Liability
Operating And Finance Lease, Liability
Total cash consideration
Payments to Acquire Businesses, Gross
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
Inventories
Deferred Tax Liabilities, Inventory
GW Incentive Plans, Post Acquisition Grants
GW Incentive Plans, Post Acquisition Grants [Member]
GW Incentive Plans, Post Acquisition Grants
Deferred tax liabilities, net
Deferred tax liabilities
Deferred Income Tax Liabilities, Net
Xyrem
Xyrem [Member]
Xyrem [Member]
Acquisition of investments
Payments to Acquire Investments
Total long-lived assets
Property, Plant And Equipment, Net, And Operating Lease Right-Of-Use Assets
Property, Plant And Equipment, Net, And Operating Lease Right-Of-Use Assets
Insider Trading Policies and Procedures [Line Items]
Exercisable, balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Rule 10b5-1 Arrangement Terminated
Rule 10b5-1 Arrangement Terminated [Flag]
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
2028
Lessee, Operating Lease, Liability, to be Paid, Year Five
Restatement does not require Recovery
Restatement Does Not Require Recovery [Text Block]
Shareholders' Equity
Equity [Text Block]
Aggregate intrinsic value, vested and expected to vest
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
ADR
ADR [Member]
Other non-current assets
Increase (Decrease) in Other Noncurrent Assets
Clinical trial accruals
Accrued Clinical Trial Liability, Current
Accrued Clinical Trial Liability, Current
Ownership [Axis]
Ownership [Axis]
Inventory-related accruals
Accrued Inventory Related Liabilities, Current
Accrued Inventory Related Liabilities, Current
Expected dividend yield (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Issuance of ordinary shares in conjunction with vesting of restricted stock units (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Totals
Financial Liabilities Fair Value Disclosure
Customer [Axis]
Customer [Axis]
Current liabilities:
Liabilities, Current [Abstract]
Ireland
Deferred Federal Income Tax Expense (Benefit)
Finance Lease Cost
Finance Lease Cost1 [Abstract]
Finance Lease Cost1
Deferred financing costs
Debt Issuance Costs, Noncurrent, Net
Change in tax rate
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount
Subsequent Event Type [Domain]
Subsequent Event Type [Domain]
Proceeds from sale of a business
Proceeds from Divestiture of Businesses
Significant Risks and Uncertainties
Significant Risks And Uncertainties [Policy Text Block]
Describes risks and uncertainties related to the pharmaceutical industry.
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Instruments, Gain (Loss) [Line Items]
Diluted (in dollars per share)
Earnings Per Share, Diluted
Accounts receivable, net of allowances of $21,136 and $17,843 at December 31, 2023 and 2022, respectively
Accounts Receivable, after Allowance for Credit Loss, Current
(Gain) loss on cash flow hedging activities reclassified from accumulated other comprehensive income (loss) to interest expense, net of income tax expense (benefit) of $1,137, $— and ($355)
(Gain) loss reclassified from accumulated other comprehensive income (loss) to interest expense, net of tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax
Accounting standards update [Extensible Enumeration]
Accounting Standards Update [Extensible Enumeration]
Teamsters And GEHA Lawsuits
Teamsters And GEHA Lawsuits [Member]
Teamsters And GEHA Lawsuits [Member]
Line of Credit
Line of Credit [Member]
Non-voting euro deferred shares, authorized (in shares)
Nonvoting Euro Preferred Shares, Shares Authorized
Nonvoting Euro Preferred Shares, Shares Authorized
Litigation Case [Axis]
Litigation Case [Axis]
Derivative asset, statement of financial position [Extensible Enumeration]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Trading Symbol
Trading Symbol
Effective Income Tax Rate Reconciliation [Abstract]
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Thereafter
Finite-Lived Intangible Asset, Expected Amortization, after Year Five
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Abstract]
Manufacturing equipment and machinery
Machinery and Equipment [Member]
Epidiolex/Epidyolex
Epidiolex/Epidyolex [Member]
Epidiolex/Epidyolex
2021 Notes
Exchangeable Senior Notes Due 2021 [Member]
Exchangeable Senior Notes Due 2021 [Member]
Amortization of debt discount
Amortization of Debt Discount (Premium)
Shareholders’ equity:
Equity, Attributable to Parent [Abstract]
Reconciliation of Unrecognized Tax Benefits
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
Basic and Diluted Net Income (Loss) per Ordinary Share Computation
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Derivative liability, statement of financial position [Extensible Enumeration]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]
2011 Equity Incentive Plan
Two Thousand Eleven Equity Incentive Plan [Member]
Two Thousand Eleven Equity Incentive Plan [Member]
Executive Category:
Executive Category [Axis]
Number of RSUs and PRSUs [Roll Forward]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Options exercised (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Land and buildings
Land and Building [Member]
Inventory, step-up value
Inventory, Step-Up Value
Inventory, Step-Up Value
2026 Notes
Exchangeable Senior Notes Due 2026 [Member]
Exchangeable Senior Notes Due 2026 [Member]
Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Inputs, Level 1 [Member]
Deferred tax assets, net of valuation allowance
Deferred Tax Assets, Net of Valuation Allowance
Schedule of Property, Plant and Equipment Estimated Useful Life
Schedule of Property, Plant and Equipment
Property, Plant and Equipment [Table Text Block]
Equity Components [Axis]
Equity Components [Axis]
Financial Instruments [Domain]
Financial Instruments [Domain]
Additional 402(v) Disclosure
Additional 402(v) Disclosure [Text Block]
Accrued liabilities
Increase (Decrease) in Accrued Liabilities
Hedging Relationship [Domain]
Hedging Relationship [Domain]
Number of shares available for issuance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
2025
Long-Term Debt, Maturity, Year Two
Options granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Prepaid expenses and other current assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets
Smaller Reporting Company
Entity Small Business
2027
Finite-Lived Intangible Asset, Expected Amortization, Year Four
Local Phone Number
Local Phone Number
Recovery of Erroneously Awarded Compensation Disclosure [Line Items]
2028
Finance Lease, Liability, to be Paid, Year Five
Notional amount
Derivative, Notional Amount
Accounts Receivable
Accounts Receivable [Member]
Measurement Frequency [Axis]
Measurement Frequency [Axis]
Restricted Stock Units (RSUs)
Restricted Stock Units (RSUs) [Member]
Schedule of RSU and PRSU Activity
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Non-voting euro deferred shares, issued (in shares)
Nonvoting Euro Deferred Shares, Shares Issued
Nonvoting Euro Deferred Shares, Shares Issued
Operating Leases
Leases, Operating [Abstract]
Accrued liabilities
Accrued Liabilities [Member]
Depreciation
Depreciation
Non-deductible compensation
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount
Trademarks
Trademarks [Member]
Retirement Benefits [Abstract]
Retirement Benefits [Abstract]
Total Neuroscience
Neuroscience [Member]
Neuroscience
Schedule of Long-term Debt
Schedule of Long-Term Debt Instruments [Table Text Block]
Research and development
Research and Development Expense (Excluding Acquired in Process Cost)
Shares withheld for payment of employee's withholding tax liability
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation
Schedule of Business Combination Consideration
Schedule of Business Acquisitions, by Acquisition [Table Text Block]
Cost of product sales (excluding amortization of acquired developed technologies)
Cost Of Product Sales Excluding Amortization Of Acquired Developed Technology And Intangible Asset Impairment
Total costs related to goods produced and sold during the reporting period excluding amortization of acquired developed technologies and intangible asset impairment presented separately.
Change in unrecognized tax benefits
Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits
Effective Income Tax Rate Reconciliation, Change In Unrecognized Tax Benefits
Variable Interest Entity
Consolidation, Variable Interest Entity, Policy [Policy Text Block]
Net income (loss) per ordinary share:
Net Income (Loss) Per Ordinary Share [Abstract]
Net Income (Loss) Per Ordinary Share
Minimum total leverage ratio, allowable restricted payments
Debt Instrument, Covenant, Minimum Total Leverage Ratio, Allowable Restricted Payments
Debt Instrument, Covenant, Minimum Total Leverage Ratio, Allowable Restricted Payments
Other assets/liabilities
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Assets (Liabilities)
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Other Assets (Liabilities)
Weighted-Average Ordinary Shares Excluded from Computation of Diluted Net Income (Loss) per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Interest expense, net
Interest Expense, Debt
Aggregate Available
Trading Arrangement, Securities Aggregate Available Amount
Domestic Plan
Domestic Plan [Member]
Research and development
Research and Development Expense [Member]
Alkem Patent Litigation
Alkem Patent Litigation [Member]
Alkem Patent Litigation
Insider Trading Policies and Procedures Not Adopted
Insider Trading Policies and Procedures Not Adopted [Text Block]
Fair value of secured debt
Notes Payable, Fair Value Disclosure
Ordinary shares (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Award Type [Axis]
Award Type [Axis]
Number of RSUs and PRSUs granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Reconciliation of Beginning and Ending Amounts of Unrecognized Tax Benefits
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
ICFR Auditor Attestation Flag
ICFR Auditor Attestation Flag
Hedging Designation [Axis]
Hedging Designation [Axis]
Operating lease assets obtained in exchange for new operating lease liabilities
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Less imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
PEO Actually Paid Compensation Amount
PEO Actually Paid Compensation Amount
Leases
Lessee, Finance Leases [Text Block]
Derivatives, Fair Value [Line Items]
Derivatives, Fair Value [Line Items]
Details of Income Tax Provision (Benefit)
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards [Line Items]
Operating lease liabilities
Operating Lease, Liability, Current
Offsetting Liabilities [Line Items]
Offsetting Liabilities [Line Items]
Prepaid expenses
Prepaid Expense, Current
Interest on lease liabilities
Finance Lease, Interest Expense
Issuance of ordinary shares under employee stock purchase plan (in shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
2026
Lessee, Operating Lease, Liability, to be Paid, Year Three
Other comprehensive income before reclassifications
OCI, before Reclassifications, Net of Tax, Attributable to Parent
Total
Finite-Lived Intangible Assets, Net
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Adoption of New Accounting Standards and Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Deferred tax asset valuation allowance
SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member]
Schedule of Offsetting Liabilities
Offsetting Liabilities [Table Text Block]
Average price of shares repurchased (in dollars per share)
Shares Acquired, Average Cost Per Share
Sumitomo
Sumitomo [Member]
Sumitomo
Initial Grant
Initial Grant [Member]
Initial Grant [Member]
Counterparty Name [Domain]
Counterparty Name [Domain]
Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization
2025
Lessee, Operating Lease, Liability, to be Paid, Year Two
Components of Income (Loss) from Continuing Operations Before Income Tax Provision (Benefit)
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
Interest income
Investment Income, Interest
Stock Price or TSR Estimation Method
Stock Price or TSR Estimation Method [Text Block]
United kingdom and united states
Income (Loss) from Continuing Operations before Income Taxes, Foreign
De-recognition of operating lease liability on lease assignment / termination
De-recognition Of Operating Lease Liability On Lease Assignment / Termination
De-recognition Of Operating Lease Liability On Lease Assignment / Termination
Total purchase consideration
Total purchase consideration
Business Combination, Consideration Transferred
Line of credit facility, commitment fee percentage (as a percentage)
Line of Credit Facility, Commitment Fee Percentage
Deferred revenue
Contract with Customer, Liability, Current
Schedule of Weighted-average Assumptions Used in Black-Scholes Option Pricing Model and Resulting Weighted-average Grant Date Fair Value of Share Options Granted
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Security Exchange Name
Security Exchange Name
Share-Based Compensation
Share-Based Payment Arrangement [Policy Text Block]
Selling, general and administrative
Selling, General and Administrative Expense
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss), Net of Tax
Collaborations, Disposition and Business Combination
Collaborative Arrangement Disclosure [Text Block]
Derivative Instruments and Hedging Activities
Derivative Instruments and Hedging Activities Disclosure [Text Block]
Share Options
Employee Stock Option [Member]
Total operating expenses
Costs and Expenses
Debt repurchased amount
Debt Instrument, Repurchased Face Amount
Maximum
Maximum [Member]
Unrecognized compensation cost related to grants under the ESPP
Unrecognized compensation cost related to grants under the PRSUs
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Document Type
Document Type
Tabular List, Table
Tabular List [Table Text Block]
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Thereafter
Long-Term Debt, Maturity, after Year Five
Inventories
Inventory, Policy [Policy Text Block]
Performance-Based Restricted Stock Units (PRSUs)
Performance-Based Restricted Stock Units (RSUs) [Member]
Performance-Based Restricted Stock Units (RSUs)
Cumulative Effect, Period of Adoption [Domain]
Cumulative Effect, Period of Adoption [Domain]
2026
Finance Lease, Liability, to be Paid, Year Three
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Derivative instrument liabilities
Derivative Liability, Current
Share-Based Compensation
Share-Based Payment Arrangement [Text Block]
Ireland
Current Federal Tax Expense (Benefit)
Other non-cash transactions
Other Noncash Income (Expense)
One-Time Payments
One-Time Payments [Member]
One-Time Payments
Debt covenant, revolving credit facility, outstanding amount threshold
Debt Covenant, Outstanding Amount Threshold
Debt Covenant, Outstanding Amount Threshold
Business Acquisition [Axis]
Business Acquisition [Axis]
Accounts receivable, allowances
Accounts Receivable, Allowance for Credit Loss, Current
Derivative [Table]
Derivative [Table]
Customer concentration risk
Customer Concentration Risk [Member]
Computer software and equipment
Computer Software And Equipment [Member]
Computer Software And Equipment [Member]
Variable Rate [Axis]
Variable Rate [Axis]
Cash
Cash [Member]
Inventory [Line Items]
Inventory [Line Items]
Raw materials
Inventory, Raw Materials, Net of Reserves
Options forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Title of 12(b) Security
Title of 12(b) Security
Other
All other
Other Countries [Member]
Other Countries [Member]
Sublease income
Sublease Income
Tiered royalty fees percentage, maximum
Tiered Royalty Fees Percentage, Maximum
Tiered Royalty Fees Percentage, Maximum
Aggregate Erroneous Compensation Not Yet Determined
Aggregate Erroneous Compensation Not Yet Determined [Text Block]
Rebates and other sales deductions
Accrued Rebates And Other Sales Deductions, Current
Carrying value as of the balance sheet date of obligations incurred through that date and payable for rebates and other sales deductions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Weighted-average grant-date fair value, outstanding, beginning balance (in dollars per share)
Weighted-average grant-date fair value, outstanding, ending balance (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Abstract]
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Expense of Enforcement, Amount
Share-based Payment Arrangement [Abstract]
Share-Based Payment Arrangement [Abstract]
Entity Tax Identification Number
Entity Tax Identification Number
Foreign exchange
Goodwill, Foreign Currency Translation Gain (Loss)
Net lease cost
Lease, Cost
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Zepzelca
Zepzelca [Member]
Zepzelca
2021 Credit Agreement, Revolving Credit Facility
Two Thousand Twenty One Credit Agreement, Revolving Credit Facility [Member]
Two Thousand Twenty One Credit Agreement, Revolving Credit Facility
Balance Sheet Location [Domain]
Balance Sheet Location [Domain]
Cumulative Effect, Period of Adoption [Axis]
Cumulative Effect, Period of Adoption [Axis]
Entity Interactive Data Current
Entity Interactive Data Current
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Table]
Debt Securities, Available-for-sale [Table]
Debt Securities, Available-for-Sale [Table]
Goodwill, Acquired In-Process Research and Development, and Intangible Assets
Goodwill and Intangible Assets, Policy [Policy Text Block]
Entity Well-known Seasoned Issuer
Entity Well-known Seasoned Issuer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Closing price of ordinary shares (USD per share)
Business Acquisition, Equity Interest Issued or Issuable, Share Price
Business Acquisition, Equity Interest Issued or Issuable, Share Price
Measure:
Measure [Axis]
Total Oncology
Oncology [Member]
Oncology
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Name
Outstanding Recovery, Individual Name
Revenue Recognition and Cost of Product Sales
Revenue from Contract with Customer [Policy Text Block]
Employee equity incentive and purchase plans
Equity Unit Purchase Agreements [Member]
Schedule of Lease Supplemental Balance Sheet Information
Assets And Liabilities, Lessee [Table Text Block]
Assets And Liabilities, Lessee [Table Text Block]
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Cardinal Health Inc
Cardinal Health Inc [Member]
Cardinal Health Inc
Advertising expenses
Advertising Expense
Luxembourg Inland Revenue
Luxembourg Inland Revenue [Member]
Schedule of Net Deferred Tax Assets and (Liabilities)
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Counterparty Name [Axis]
Counterparty Name [Axis]
Derivative Instruments and Hedging Activities
Derivatives, Policy [Policy Text Block]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
2024
Finite-Lived Intangible Asset, Expected Amortization, Year One
Operating cash outflows from operating leases
Operating Lease, Payments
Ordinary shares, outstanding (in shares)
Beginning balance (in shares)
Ending balance (in shares)
Common Stock, Shares, Outstanding
Income Tax Benefit
Income Tax Expense (Benefit), Continuing Operations [Abstract]
ESSDS
Express Scripts [Member]
Express Scripts 1 [Member]
Total deferred, change in tax rates
Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate
Deferred Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate
Senior Secured Debt
Senior Secured Debt [Member]
Senior Secured Debt
PEO
PEO [Member]
Concentrations of Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Auditor Location
Auditor Location
Employee Benefit Plans
Retirement Benefits [Text Block]
Increase (Decrease) in Accumulated Other Comprehensive Income (Loss) [Roll Forward]
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Deduction on subsidiary equity
Effective Income Tax Rate Reconciliation, Equity In Earnings (Losses) Of Consolidated Subsidiary, Amount
Effective Income Tax Rate Reconciliation, Equity In Earnings (Losses) Of Consolidated Subsidiary, Amount
Percentage of conversion price
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger
De-recognition of operating lease asset on lease assignment / termination
De-recognition Of Operating Lease Asset On Lease Assignment / Termination
De-recognition Of Operating Lease Asset On Lease Assignment / Termination
Defined Contribution Plan Disclosure [Line Items]
Defined Contribution Plan Disclosure [Line Items]
Ordinary shares, nominal value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Finance Leases
Finance Lease, Liability [Abstract]
Net cash used in investing activities
Net Cash Provided by (Used in) Investing Activities
Interest Rate Swap
Interest Rate Swap [Member]
Debt Instrument [Axis]
Debt Instrument [Axis]
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Revenue of acquiree since acquisition date, actual
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual
Shares repurchased
Stock Repurchased and Retired During Period, Value
Outstanding Aggregate Erroneous Compensation Amount
Outstanding Aggregate Erroneous Compensation Amount
Deferred tax liabilities:
Deferred Tax Liabilities, Gross [Abstract]
Measurement Input Type [Domain]
Measurement Input Type [Domain]
Other Current Assets [Abstract]
Other Current Assets
Credit Facility [Axis]
Credit Facility [Axis]
Derivative Financial Instruments
Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Security Not Offset
Income tax expense (benefit) on unrealized loss on hedging activities
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax
Schedule of Maturities of Long-term Debt
Schedule of Maturities of Long-Term Debt [Table Text Block]
Total current tax expense
Current Income Tax Expense (Benefit)
Volatility (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Total deferred, exclusive of other components
Deferred Income Tax Expense (Benefit), Before Effect Of Change In Tax Rates
Deferred Income Tax Expense (Benefit), Before Effect Of Change In Tax Rates
Authorized but unissued ordinary shares reserved (in shares)
Common Stock, Capital Shares Reserved for Future Issuance
Measurement Frequency [Domain]
Measurement Frequency [Domain]
Property, Plant and Equipment
Property, Plant and Equipment Disclosure [Text Block]
Non-Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted [Flag]
Capitalized research and development
Deferred Tax Assets, in Process Research and Development
Stockholders' Equity Note [Line Items]
Stockholders Equity Note [Line Items]
Stockholders Equity Note [Line Items]
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset [Domain]
Credit Agreement June 2015
Credit Agreement June 2015 [Member]
Credit Agreement June 2015 [Member]
Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]
Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]
Decrease in unrecognized tax benefits is reasonably possible
Decrease in Unrecognized Tax Benefits is Reasonably Possible
Consulting and professional services
Accrued Professional Fees, Current
Summary Of Deferred Revenue [Line Items]
Summary Of Deferred Revenue [Line Items]
[Line Items] for Summary Of Deferred Revenue [Table]
Awards Close in Time to MNPI Disclosures, Table
Awards Close in Time to MNPI Disclosures [Table Text Block]
Total current assets
Assets, Current
Intangible asset impairment charge
Asset Impairment Charges
Supplemental disclosure of cash flow information:
Supplemental Cash Flow Information [Abstract]
Non-voting Euro Deferred
Euro Deferred Shares [Member]
Euro Deferred Shares [Member]
Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block]
Auditor Information [Abstract]
Auditor Information
Stock repurchased (in shares)
Stock Repurchased During Period, Shares
Tax deficiencies/(excess tax benefits) from share-based compensation
Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Amount
Schedule of Income (Losses) on Derivative Instruments
Schedule Of Fair Value Hedges Included In Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Schedule Of Fair Value Hedges Included In Accumulated Other Comprehensive Income (Loss)
Concentration risk, percentage
Concentration Risk, Percentage
Current
Current Income Tax Expense (Benefit), Continuing Operations [Abstract]
Components of Accumulated Other Comprehensive Loss
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Investments
Investments
Weighted-average grant-date fair value, RSUs and PRSUs granted (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
2028
Finite-Lived Intangible Asset, Expected Amortization, Year Five
Options expired (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Ireland
IRELAND
2027
Finance Lease, Liability, to be Paid, Year Four
Valuation, Income Approach
Valuation, Income Approach [Member]
Net cash provided by operating activities
Net Cash Provided by (Used in) Operating Activities
Aggregate intrinsic value, exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Schedule of Estimated Future Amortization Costs
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Class of Stock [Axis]
Class of Stock [Axis]
Erroneously Awarded Compensation Recovery
Erroneously Awarded Compensation Recovery [Table]
Aggregate Intrinsic Value
Aggregate Intrinsic Value [Abstract]
Aggregate Intrinsic Value [Abstract]
Dilutive effect of exchangeable senior notes (in shares)
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
Provision for losses on accounts receivable and inventory
Provision For Losses On Accounts Receivable And Inventory
Amount of the current period expense charged against operations (1) for the purpose of reducing receivables to an amount that approximates their net realizable value and (2) the charge to cost of goods sold that represents the reduction off the carrying amount of inventory, generally attributable to obsolescence or market conditions.
Acquisition accounting inventory fair value step-up adjustment
Inventory Step-Up Value Adjustment
Inventory Step-Up Value Adjustment
Sativex
Sativex [Member]
Sativex
Italy
ITALY
Debt Instrument, Redemption, Period Three
Debt Instrument, Redemption, Period Three [Member]
Depreciation and amortization expense
Depreciation, Depletion and Amortization
Deferred tax assets:
Deferred Tax Assets, Gross [Abstract]
Deferred Financing Costs
Financing Costs [Policy Text Block]
Financing Costs [Policy Text Block]
Furniture and fixtures
Furniture and fixtures
Furniture and Fixtures [Member]
Award Timing, How MNPI Considered
Award Timing, How MNPI Considered [Text Block]
Non-deductible acquisition-related costs
Effective Income Tax Rate Reconciliation, Acquisition-Related Costs, Amount
Effective Income Tax Rate Reconciliation, Acquisition-Related Costs, Amount
Payment terms, range
Revenue, Performance Obligation, Payment Terms
Revenue, Performance Obligation, Payment Terms
Allowance for doubtful accounts
SEC Schedule, 12-09, Allowance, Credit Loss [Member]
Tiered royalty fees percentage, minimum
Tiered Royalty Fees Percentage, Minimum
Tiered Royalty Fees Percentage, Minimum
Deferred tax assets, valuation allowance
Valuation allowance
Deferred Tax Assets, Valuation Allowance
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]
Net Unrealized Gain From Hedging Activities
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]
Deferred tax liabilities, net
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities
Equity securities without readily determinable value, fair value
Equity Securities without Readily Determinable Fair Value, Amount
Net income (loss) per ordinary share:
Earnings Per Share Reconciliation [Abstract]
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Axis]
Non-deductible financing costs
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Financing Costs, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Financing Costs, Amount
Emerging Growth Company
Entity Emerging Growth Company
United Kingdom
UNITED KINGDOM
Debt issuance cost
Debt Issuance Costs, Net
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Other non-current assets
Other Noncurrent Assets [Member]
Total deferred tax assets
Deferred Tax Assets, Gross
Total acquired identifiable intangible assets
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles
2024
Lessee, Operating Lease, Liability, to be Paid, Year One
Pay vs Performance Disclosure, Table
Pay vs Performance [Table Text Block]
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Title
Trading Arrangement, Individual Title
Loss recognized in accumulated other comprehensive income (loss), net of tax
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Tax and Reclassification Adjustment
Ordinary Shares
Common Stock [Member]
Individual:
Individual [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Other
Deferred Other Tax Expense (Benefit)
Lapse of the applicable statute of limitations
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations
Income Statement Location [Domain]
Income Statement Location [Domain]
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]
Repayments of long-term debt
Repayments of Secured Debt
Gross Amounts Not Offset in the Consolidated Balance Sheet
Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction [Abstract]
United kingdom and united states
Deferred Foreign Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate
Deferred Foreign Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate
Product sales, net
Product And Services, Product Sales Net Of Deductions [Member]
Product And Services, Product Sales Net Of Deductions [Member]
Asset Derivatives
Derivative Asset, Fair Value, Gross Asset Including Not Subject to Master Netting Arrangement
Minimum
Minimum [Member]
Potential Milestone Payment
Potential Milestone Payment [Member]
Potential Milestone Payment
Gain recognized in AOCI to be reclassified over the next 12 months
Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months
Disposal Group Classification [Axis]
Disposal Group Classification [Axis]
Statement of Cash Flows [Abstract]
Statement of Cash Flows [Abstract]
Assets
Assets:
Assets [Abstract]
Award Timing MNPI Disclosure
Award Timing MNPI Disclosure [Text Block]
Schedule of the Fair Value of Outstanding Derivatives
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]
Foreign exchange gain (loss)
Gain (Loss), Foreign Currency Transaction, before Tax
Payment of employee withholding taxes related to share-based awards
Payment, Tax Withholding, Share-Based Payment Arrangement
Schedule II Valuation and Qualifying Accounts
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
Other
Deferred Tax Assets, Other
Liabilities
Liabilities [Abstract]
Other current assets
Other Current Assets [Member]
Net cash (used in) provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Deferred tax assets, net
Deferred tax assets
Deferred Income Tax Assets, Net
Malta
MALTA
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Retained Earnings
Retained Earnings [Member]
Current portion of long-term debt
Less current portion
Long-Term Debt, Current Maturities
Infringed patents suit, number of patents
Gain Contingency, Patents Allegedly Infringed upon, Number
Adjustment to Non-PEO NEO Compensation Footnote
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Basic (in dollars per share)
Earnings Per Share, Basic
Unrecognized compensation cost related to unvested stock options
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Lupin Lawsuit
Lupin Lawsuit [Member]
Lupin Lawsuit
Issuance of ordinary shares under employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Accounting Policies [Abstract]
Accounting Policies [Abstract]
Erroneous Compensation Analysis
Erroneous Compensation Analysis [Text Block]
Aggregate intrinsic value of share options exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value
Acquisition accounting inventory fair value step-up adjustment
Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory
Cash paid for income taxes, net of refunds
Income Taxes Paid
Basis of Presentation
Consolidation, Policy [Policy Text Block]
Operating lease, liability, current, statement of financial position [Extensible List]
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Document Transition Report
Document Transition Report
Award Timing Predetermined
Award Timing Predetermined [Flag]
Schedule of Business Acquisitions, by Acquisition [Table]
Schedule of Business Acquisitions, by Acquisition [Table]
Fair value of exchangeable senior notes
Convertible Debt, Fair Value Disclosures
Five Customers
Five Customers [Member]
Five Customers
Accounts payable
Increase (Decrease) in Accounts Payable
Repayments under revolving credit facility
Repayments of Lines of Credit
Entity Public Float
Entity Public Float
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
2024 Notes
Exchangeable Senior Notes Due 2024 [Member]
Exchangeable Senior Notes Due 2024 [Member]
Summary of Revenues from Customers Representing More Than 10% of Total Revenues
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Abstract]
Capital Redemption Reserve
Capital Redemption Reserve [Member]
Capital Redemption Reserve [Member]
Entity Address, Country
Entity Address, Country
Derivative Instrument [Axis]
Derivative Instrument [Axis]
Increase in valuation allowance
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Long term debt outstanding
Total
Long-Term Debt, Gross
All Trading Arrangements
All Trading Arrangements [Member]
Loss on disposal
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
Less accumulated depreciation and amortization
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization
All Adjustments to Compensation
All Adjustments to Compensation [Member]
Non-cash interest expense
Noncash Interest Expense
Noncash Interest Expense
Compensation Amount
Outstanding Recovery Compensation Amount
2007 Directors Award Plan
Two Thousand Seven Non Employee Directors Stock Award Plan [Member]
Two Thousand Seven Non Employee Directors Stock Award Plan [Member]
Derivative asset
Net Amounts of Assets/ Liabilities Presented in the Consolidated Balance Sheet
Derivative Asset
Weighted-average grant-date fair value, RSUs and PRSUs forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Operating lease assets
Deferred Tax Liabilities, Leasing Arrangements
Deferred tax expense (benefit)
Total deferred tax expense (benefit)
Deferred Income Tax Expense (Benefit)
Subsequent Event Type [Axis]
Subsequent Event Type [Axis]
Statement of Comprehensive Income [Abstract]
Statement of Comprehensive Income [Abstract]
Term Loan
Term Loan
Term Loan [Member]
Term Loan [Member]
Present value of lease liabilities
Finance Lease, Liability
Convertible Debt
Convertible Debt [Member]
Options forfeited (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Document Financial Statement Error Correction
Document Financial Statement Error Correction [Flag]
Number of RSUs and PRSUs forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Ordinary shares issued to GW ADS holders (in shares)
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares
Epidiolex Patent Litigation
Epidiolex Patent Litigation [Member]
Epidiolex Patent Litigation
Manufacturing contracts
Manufacturing Contracts [Member]
Manufacturing Contracts [Member]
Upfront Payment
Upfront Payments [Member]
Upfront Payments [Member]
Other Current Assets
Other Current Assets [Text Block]
2024
Long-Term Debt, Maturity, Year One
Debt Instrument, Redemption, Period One
Debt Instrument, Redemption, Period One [Member]
Dilutive effect of employee equity incentive and purchase plans (in shares)
Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements
Issuance of ordinary shares in connection with the acquisition of GW Pharmaceuticals plc (in shares)
Stock Issued During Period, Shares, Acquisitions
Documents Incorporated by Reference
Documents Incorporated by Reference [Text Block]
Document Period End Date
Document Period End Date
Adoption Date
Trading Arrangement Adoption Date
Total Revenues
Revenue from Contract with Customer Benchmark [Member]
Finance leases
Finance Lease, Weighted Average Discount Rate, Percent
Finance lease liabilities
Finance Lease, Liability, Noncurrent
Capital redemption reserve
Capital Redemption Reserve
Capital redemption reserve created under Irish company law to preserve permanent capital in the company.
Income tax expense (benefit)
Total income tax expense (benefit)
Income Tax Expense (Benefit)
Weighted-average remaining contractual term, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Derivatives designated as hedging instruments
Designated as Hedging Instrument [Member]
Finance lease assets
Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Valuation Approach and Technique [Domain]
Valuation Approach and Technique [Domain]
Fair Value Measurement
Fair Value Disclosures [Text Block]
Number of operating business segments
Number of Operating Segments
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents [Abstract]
Ordinary Shares
Ordinary Shares [Member]
Ordinary Shares [Member]
Valuation Allowance, Operating Loss Carryforwards
SEC Schedule, 12-09, Valuation Allowance, Operating Loss Carryforward [Member]
Stockholders' Equity Note [Table]
Stockholders Equity Note [Table]
Stockholders Equity Note [Table]
Equity [Abstract]
Equity [Abstract]
Debt Securities, Available-for-sale [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Inventories
Inventory Disclosure [Text Block]
Operating leases
Operating Lease, Weighted Average Remaining Lease Term
Maximum secured leverage ratio, for restricted payments to be allowed
Debt Instrument, Covenant, Maximum Secured Leverage Ratio, For Restricted Payments To Be Allowed
Debt Instrument, Covenant, Maximum Secured Leverage Ratio, For Restricted Payments To Be Allowed
Weighted-average discount rate
Weighted Average Discount Rate [Abstract]
Weighted Average Discount Rate
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Offsetting Liabilities [Table]
Offsetting Liabilities [Table]
Money market funds
Money Market Funds [Member]
Tax credit carryforwards
Tax Credit Carryforward, Amount
Cash and cash equivalents
Cash and Cash Equivalents
Cash and Cash Equivalents, at Carrying Value
Shares withheld for tax purposes (in shares)
Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Acquisition of a business, net of cash acquired
Payments to Acquire Businesses, Net of Cash Acquired
Credit Facility [Domain]
Credit Facility [Domain]
Shares repurchased (in shares)
Stock Repurchased and Retired During Period, Shares
Time deposits
Bank Time Deposits [Member]
Basis spread on variable rate
Debt Instrument, Basis Spread on Variable Rate
Net Amount
Derivative Asset, Including Not Subject to Master Netting Arrangement, after Offset and Deduction
Estimated useful life of property and equipment
Property, Plant and Equipment, Useful Life
Compensation Actually Paid vs. Other Measure
Compensation Actually Paid vs. Other Measure [Text Block]
Denominator:
Denominator [Abstract]
Denominator [Abstract]
Interest rate contracts
Interest Rate Contract [Member]
Finance lease assets obtained in exchange for new finance lease liabilities
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability
Less imputed interest
Finance Lease, Liability, Undiscounted Excess Amount
Revenues
Revenue from Contract with Customer [Text Block]
Decreases related to settlements with taxing authorities
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
Additional paid-in capital
Additional Paid in Capital, Common Stock
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Unrealized gain (loss) on cash flow hedging activities, net of income tax expense (benefit) of $1,215, $— and ($2), respectively
Gain (loss) recognized in accumulated other comprehensive income (loss), net of tax
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax
Document Annual Report
Document Annual Report
Balance Sheet Location [Axis]
Balance Sheet Location [Axis]
Equity in loss of investees
Income (Loss) from Equity Method Investments
Cover [Abstract]
Cover [Abstract]
Amortization of debt issuance costs
Amortization of Debt Issuance Costs
United States
UNITED STATES
Maximum allowable restricted payments
Debt Instrument, Covenant, Maximum Allowable Restricted Payments
Debt Instrument, Covenant, Maximum Allowable Restricted Payments
Recurring
Fair Value, Recurring [Member]
Werewolf
Werewolf [Member]
Werewolf
Other non-current liabilities
Other Liabilities, Noncurrent
Total lease payments
Lessee, Operating Lease, Liability, to be Paid
Avadel Pharmaceuticals plc Lawsuit
Avadel Pharmaceuticals plc Lawsuit [Member]
Avadel Pharmaceuticals plc Lawsuit
Cash Flow Hedges
Cash Flow Hedging [Member]
Amortization of leased asset
Finance Lease, Right-of-Use Asset, Amortization
Segment and Other Information
Segment Reporting Disclosure [Text Block]
Net increase (decrease) in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Income Tax Authority, Name [Domain]
Income Tax Authority, Name [Domain]
Equity Component [Domain]
Equity Component [Domain]
Finance lease liabilities
Finance Lease, Liability, Current
GW ADS outstanding (in shares)
Business Combination, Number Of American Depository Shares Acquired
Business Combination, Number Of American Depository Shares Acquired
Schedule of Offsetting Assets
Offsetting Assets [Table Text Block]
U.S. State
State and Local Jurisdiction [Member]
Work in process
Inventory, Work in Process, Net of Reserves
Non-GAAP Measure Description
Non-GAAP Measure Description [Text Block]
Other
Deferred Tax Liabilities, Other
Components of Inventories
Inventory, Net, Items Net of Reserve Alternative [Abstract]
Entity Current Reporting Status
Entity Current Reporting Status
Offsetting Assets [Line Items]
Offsetting Assets [Line Items]
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Income (loss) from operations
Operating Income (Loss)
Maximum allowable dividend and restricted payments
Debt Instrument, Covenant, Maximum Allowable Dividend And Restricted Payments
Debt Instrument, Covenant, Maximum Allowable Dividend And Restricted Payments
Total deferred tax liabilities
Deferred Tax Liabilities, Gross
Debt instrument, redemption price, percentage of principal amount redeemed (as a percent)
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed
Cash and Available-for-Sale Securities
Cash, Cash Equivalents, and Short-Term Investments [Text Block]
Zymeworks
Zymeworks [Member]
Zymeworks
Property, Plant and Equipment
Property, Plant and Equipment, Policy [Policy Text Block]
Other comprehensive income (loss):
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other
Income (Loss) From Continuing Operations, Before Income Taxes, Foreign, Other
Income (Loss) From Continuing Operations, Before Income Taxes, Foreign, Other
Scenario [Domain]
Scenario [Domain]
Weighted- Average Remaining Contractual Term (Years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Awards Close in Time to MNPI Disclosures
Awards Close in Time to MNPI Disclosures [Table]
Transactions costs incurred during period
Business Acquisition, Transactions Costs Incurred During Period
Business Acquisition, Transactions Costs Incurred During Period
ASD Specialty Healthcare LLC
ASD Specialty Healthcare LLC [Member]
ASD Specialty Healthcare LLC
Components of Income from Continuing Operations before Income Tax Provision (Benefit)
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
GW Litigation
GW Litigation [Member]
GW Litigation
Variable Rate [Domain]
Variable Rate [Domain]
Pay vs Performance Disclosure [Line Items]
Other royalty and contract revenues
Product And Services, Other Royalties And Contract Revenue [Member]
Product And Services, Other Royalties And Contract Revenue
Entity Voluntary Filers
Entity Voluntary Filers
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Underlying Security Market Price Change
Underlying Security Market Price Change, Percent
Accrued royalties
Accrued Royalties, Current
Cash and cash equivalents
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents
Number of consecutive days in trading period
Debt Instrument, Convertible, Threshold Consecutive Trading Days
Non-deductible facility expense
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Facility Expense, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Facility Expense, Amount
Number of RSUs and PRSUs, outstanding, beginning balance (in shares)
Number of RSUs and PRSUs, outstanding, ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Debt
Debt Disclosure [Text Block]
Statement of Stockholders' Equity [Abstract]
Statement of Stockholders' Equity [Abstract]
Offsetting Assets [Table]
Offsetting Assets [Table]
Research and Development
Research and Development Expense, Policy [Policy Text Block]
Cross-currency interest rate contracts
Cross Currency Interest Rate Contract [Member]
Borrowings under revolving credit facility
Revolving Credit Facility [Member]
Cash, Cash Equivalents and Investments
Cash, Cash Equivalents and Investments [Table Text Block]
Effect of exchange rates on cash and cash equivalents
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Intangible asset impairment charge
Impairment of Intangible Assets, Finite-Lived
MNPI Disclosure Timed for Compensation Value
MNPI Disclosure Timed for Compensation Value [Flag]
Segment Reporting [Abstract]
Segment Reporting [Abstract]
Accounts payable
Accounts Payable, Current
Weighted-average remaining contractual term, exercisable (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Computer equipment
Computer Equipment [Member]
Net loss of acquiree since acquisition date, actual
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual
Restatement Determination Date:
Restatement Determination Date [Axis]
Other non-current liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Commitments and contingencies (Note 14)
Commitments and Contingencies
Non-voting euro deferred shares, par value (in euros per share)
Nonvoting Euro Deferred Shares, Par or Stated Value Per Share
Nonvoting Euro Deferred Shares, Par or Stated Value Per Share
Geographical [Axis]
Geographical [Axis]
Requisite service periods (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period
Foreign Plan
Foreign Plan [Member]
Income Taxes
Income Tax Disclosure [Text Block]
Deferred revenue
Increase (Decrease) in Contract with Customer, Liability
FDA stay of approval period
FDA Stay Of Approval Period
FDA Stay Of Approval Period
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Property, plant and equipment, gross
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization
Other
Other Assets, Miscellaneous, Current
Leases
Lessee, Leases [Policy Text Block]
Property, plant and equipment
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment
Contractual coupon rate interest expense
Interest Expense, Debt, Contractual Coupon Rate
Interest Expense, Debt, Contractual Coupon Rate
Change in valuation allowance
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount
Business Acquisition [Line Items]
Business Acquisition [Line Items]
Weighted- Average Grant-Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Recurring and Nonrecurring [Table]
Gross Amounts of Recognized Assets/ Liabilities
Derivative Liability, Subject to Master Netting Arrangement, before Offset
PEO Total Compensation Amount
PEO Total Compensation Amount
Hedging Relationship [Axis]
Hedging Relationship [Axis]
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Table]
Goodwill [Roll Forward]
Goodwill [Roll Forward]
Vested and expected to vest (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Cash consideration per GW ADS (USD per share)
Business Acquisition, Share Price
Trading Arrangements, by Individual
Trading Arrangements, by Individual [Table]
Non-deductible royalty expense
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Royalty Expense, Amount
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Royalty Expense, Amount
Outstanding, beginning balance (in shares)
Outstanding, ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Employee compensation and benefits
Accrued Employee Benefits, Current
Issuance of ordinary shares in conjunction with exercise of share options
Stock Issued During Period, Value, Stock Options Exercised
Non-PEO NEO Average Compensation Actually Paid Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Schedule of Other Current Assets
Schedule of Other Current Assets [Table Text Block]
Grant date fair value (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Net income (loss)
Net income (loss)
Net (loss) income
Net Income (Loss)
Total current liabilities
Liabilities, Current
Allowance for chargebacks
Allowance For Chargebacks [Member]
Allowance For Chargebacks [Member]
Derivative Contract [Domain]
Derivative Contract [Domain]
2025
Finance Lease, Liability, to be Paid, Year Two
Foreign Currency
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Changed Peer Group, Footnote
Changed Peer Group, Footnote [Text Block]
Company Selected Measure Name
Company Selected Measure Name
Leases
Lessee, Operating Leases [Text Block]
Accrued interest
Interest Payable, Current
Property, plant and equipment, net
Property, plant and equipment, net
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
LIABILITIES AND SHAREHOLDERS’ EQUITY
Liabilities and Equity [Abstract]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets [Line Items]
Payments for repurchase of Exchangeable Senior Notes, due 2021
Repayments of Convertible Debt
Stock repurchased
Stock Repurchased During Period, Value
Debt Instrument, Redemption, Period [Axis]
Debt Instrument, Redemption, Period [Axis]
Derivative Instruments, Gain (Loss) [Table]
Derivative Instruments, Gain (Loss) [Table]
Disposal group, not discontinued operation, gain (loss) on disposal, statement of income or comprehensive income [Extensible Enumeration]
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]
Amounts reclassified from accumulated other comprehensive income (loss)
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent
Gross Unrealized Losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Issuance of ordinary shares in conjunction with exercise of share options (in shares)
Options exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Ireland
Income (Loss) from Continuing Operations before Income Taxes, Domestic
Accrued collaboration expenses
Accrued Collaboration Expenses, Current
Accrued Collaboration Expenses, Current
Number o days requested for FDA to take action
Plaintiff, Number Of Days Requested For FDA To Take Action
Plaintiff, Number Of Days Requested For FDA To Take Action
U.S. Federal
Internal Revenue Service (IRS) [Member]
Vesting period (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Remaining Weighted- Average Useful Life (In years)
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life
Schedule of Authorized but Unissued Ordinary Shares
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
Name
Measure Name
Name
Forgone Recovery, Individual Name
Goodwill
Goodwill, beginning of period
Goodwill, end of period
Goodwill
Increases related to prior year tax positions
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions
Underlying Securities
Award Underlying Securities Amount
Contingent Consideration by Type [Axis]
Contingent Consideration by Type [Axis]
Comprehensive Income (Loss)
Comprehensive Income (Loss) Note [Text Block]
Accounts receivable
Increase (Decrease) in Accounts Receivable
Selling, general and administrative
Selling, General and Administrative Expenses [Member]
Operating lease liabilities, less current portion
Operating Lease, Liability, Noncurrent
Jazz Investments I Limited
Jazz Investments I Limited [Member]
Jazz Investments I Limited [Member]
Debt term (in years)
Debt Instrument, Term
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Indirect effects of unrecognized tax benefits
Deferred Tax Assets, Indirect Effects Of Unrecognized Tax Benefits
Deferred Tax Assets, Indirect Effects Of Unrecognized Tax Benefits
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjustment [Member]
Erwinaze/Erwinase
Erwinaze And Erwinase [Member]
Erwinaze And Erwinase [Member]
Income Statement Location [Axis]
Income Statement Location [Axis]
Total share-based compensation expense, net of tax
Share-Based Payment Arrangement, Expense, after Tax
Contingencies
Commitments and Contingencies, Policy [Policy Text Block]
Schedule of Operating Lease Liability Maturities
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Foreign exchange forward contracts
Foreign Exchange Forward [Member]
Europe
Europe [Member]
Cumulated unremitted earnings of overseas subsidiaries
Undistributed Earnings of Foreign Subsidiaries
Defined Contribution Plan [Table]
Defined Contribution Plan [Table]
Payables and Accruals [Abstract]
Payables and Accruals [Abstract]
Product and Service [Domain]
Product and Service [Domain]
Other Performance Measure, Amount
Other Performance Measure, Amount
Accrued liabilities
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals
Cash Collateral Received (Pledged)
Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Not Offset
Schedule of Lease Cost and Supplemental Cash Flow Information
Lease, Cost [Table Text Block]
Inventories
Increase (Decrease) in Inventories
Gross Amounts Not Offset in the Consolidated Balance Sheet
Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction [Abstract]
Investing activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Loss on fair value hedging activities reclassified from accumulated other comprehensive income (loss) to foreign exchange gain (loss), net of income tax benefit of $—, $43, and $—, respectively
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification and Tax,
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification and Tax,
FDA recognition of orphan drug exclusivity, period
FDA Recognition Of Orphan Drug Exclusivity, Period
FDA Recognition Of Orphan Drug Exclusivity, Period
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Plan Name [Domain]
Plan Name [Domain]
Repayment of debt
Payment for Debt Extinguishment or Debt Prepayment Cost
Unrecognized compensation cost related to unvested RSUs
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Shares authorized for issuance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized
Weighted-average remaining contractual term, outstanding (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Trading Arrangement:
Trading Arrangement [Axis]
Operating Loss Carryforwards [Table]
Operating Loss Carryforwards [Table]
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Effect of interest on assumed conversions of Exchangeable Senior Notes, net of tax
Interest on Convertible Debt, Net of Tax
Long-term Debt, Type [Domain]
Long-Term Debt, Type [Domain]
Available-for-sale securities:
Debt Securities, Available-for-Sale [Abstract]
Entity File Number
Entity File Number
Secured Notes
Senior Notes Due 2029 [Member]
Senior Notes Due 2029
Thereafter
Lessee, Operating Lease, Liability, to be Paid, after Year Five
Measurement Input, Discount Rate
Measurement Input, Discount Rate [Member]
2026
Long-Term Debt, Maturity, Year Three
Decreases related to prior year tax positions
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Auditor Firm ID
Auditor Firm ID
Intangible asset amortization
Intangible asset amortization
Amortization of Intangible Assets
Entity Shell Company
Entity Shell Company
Business Acquisition, Acquiree [Domain]
Business Acquisition, Acquiree [Domain]
Range of risk-free rates, minimum (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Restatement Determination Date
Restatement Determination Date
Lease liabilities
Deferred Tax Assets, Operating Lease Liability
Deferred Tax Assets, Operating Lease Liability
Xywav
Xywav [Member]
Xywav
Income taxes payable
Increase (Decrease) in Income Taxes Payable
Increases related to current year tax positions
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Rule 10b5-1 Arrangement Adopted
Rule 10b5-1 Arrangement Adopted [Flag]
Cash and cash equivalents, at beginning of period
Cash and cash equivalents, at end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Fair value of lines of credit
Lines of Credit, Fair Value Disclosure
Sales return reserve
Sales Return Reserve, Current
Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales returns reserve. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Variable lease cost
Variable Lease, Cost
Operating lease cost
Operating Lease, Cost
Ordinary shares, issued (in shares)
Common Stock, Shares, Issued
Number of RSUs released (in shares)
Number of RSUs and PRSUs released (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Proceeds from maturity of investments
Proceeds from Sale, Maturity and Collection of Investments
Unrealized loss on fair value hedging activities, net of income tax benefit of $—, $— and $43, respectively
Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax
Country Region
Country Region
Research and other tax credits
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Total debt
Long-Term Debt
Totals
Assets, Fair Value Disclosure
2027
Long-Term Debt, Maturity, Year Four
Milestone Payment
Milestone Payment [Member]
Milestone Payment [Member]
Foreign Currency Translation Adjustments
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]
Farrell Lawsuit And Levy Lawsuit
Farrell Lawsuit And Levy Lawsuit [Member]
Farrell Lawsuit And Levy Lawsuit
Balance at beginning of period
Balance at end of period
SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount
Unrecognized compensation cost, weighted-average period of recognition (in years)
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Total comprehensive income (loss)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Number of purchase periods within each ESPP offering period
Share-based Compensation Arrangement by Share-based Payment Award, Number of Purchase Periods Within Each Offering Period
Number of purchase periods within a fixed offering period with respect to the plan.
Ireland
Domestic Tax Authority [Member]
Short-term lease cost
Short-Term Lease, Cost
Issuance of ordinary shares arising from the acquisition of GW and share-based payment - pre-combination service
Stock Issued During Period, Value, Acquisitions
Entity Address, Address Line One
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Two
Components of Net Deferred Tax Assets/(Liabilities)
Components of Deferred Tax Assets and Liabilities [Abstract]
Ownership percentage (as a percent)
Subsidiary, Ownership Percentage, Parent
2024
Finance Lease, Liability, to be Paid, Year One
Weighted- Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Income taxes payable
Taxes Payable, Current
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Net asset fair value
Derivative, Fair Value, Net
Subsequent Event
Subsequent Event [Member]
NOL carryforwards
Operating Loss Carryforwards
2021 Credit Agreement, Euro Term Loan
Two Thousand Twenty One Credit Agreement, Euro Term Loan [Member]
Two Thousand Twenty One Credit Agreement, Euro Term Loan
Schedule of Gross Carrying Amounts and Net Book Values of Intangible Assets
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Additional expected tax expense if foreign earnings repatriated
Additional Expected Tax Expense If Foreign Earnings Repatriated In The Future
Additional Expected Tax Expense If Foreign Earnings Repatriated In The Future
Income Statement [Abstract]
Income Statement [Abstract]
Deduction on subsidiary equity carryforwards
Deferred Tax Assets, Deductions On Subsidiary Equity
Deferred Tax Assets, Deductions On Subsidiary Equity
Long-Term Purchase Commitment [Table]
Long-Term Purchase Commitment [Table]
Annual Automatic Grant
Annual Automatic Grant [Member]
Annual Automatic Grant [Member]
Valuation Approach and Technique [Axis]
Valuation Approach and Technique [Axis]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Adopted [Flag]
Derivative Liability
Net Amounts of Assets/ Liabilities Presented in the Consolidated Balance Sheet
Derivative Liability
Other current assets
Total other current assets
Other Assets, Current
Non-voting euro deferred shares, €0.01 par value per share; 4,000 shares authorized, issued and outstanding at both December 31, 2023 and 2022
Nonvoting Euro Deferred Shares
Shares issued to satisfy statutory minimum of Euro-denominated share capital required for a public limited company incorporated in Ireland.
Income tax expense (benefit) at the statutory income tax rate
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
Autifony Therapeutics
Autifony Therapeutics [Member]
Autifony Therapeutics
Inventories
Total inventories
Inventory, Net
Outside United States
Outside United States
Domestic and Foreign, Excluding United States [Member]
Domestic and Foreign, Excluding United States
Financial Instrument [Axis]
Financial Instrument [Axis]
ESPP offering period (in months)
Share-based Compensation Arrangement by Share-based Payment Award, Offering Period
Fixed offering period (months) with respect to the plan.
Advertising Expenses
Advertising Cost [Policy Text Block]
Total Shareholder Return Amount
Total Shareholder Return Amount
Summary Of Deferred Revenue [Table]
Summary Of Deferred Revenue [Table]
Summary Of Deferred Revenue [Table]
Share repurchases
Payments for Repurchase of Common Stock
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Pro Forma
Pro Forma [Member]
Adjustment To PEO Compensation, Footnote
Adjustment To PEO Compensation, Footnote [Text Block]
United kingdom and united states
Deferred Foreign Income Tax Expense (Benefit)
Inventory Disclosure [Abstract]
Inventory Disclosure [Abstract]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Retained earnings
Retained Earnings (Accumulated Deficit)
Teva Lawsuit
Teva Lawsuit [Member]
Teva Lawsuit
Debt instrument, face amount
Debt Instrument, Face Amount
Upfront payment received
Disposal Group, Not Discontinued Operation, Upfront Payment Received
Disposal Group, Not Discontinued Operation, Upfront Payment Received
Current assets:
Assets, Current [Abstract]
Leases [Abstract]
Leases [Abstract]
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Schedule of Revenues from External Customers and Long-Lived Assets [Table]
Schedule of Revenues from External Customers and Long-Lived Assets [Table]
Total lease payments
Finance Lease, Liability, to be Paid
Operating activities
Net Cash Provided by (Used in) Operating Activities [Abstract]
Patent box incentive benefit
Effective Income Tax Rate Reconciliation, Patent Box Incentive Benefit, Amount
Effective Income Tax Rate Reconciliation, Patent Box Incentive Benefit, Amount
Debt conversion price (in dollars per share)
Debt Instrument, Convertible, Conversion Price
Conversion rate of shares (in shares per dollar)
Debt Instrument, Convertible, Conversion Ratio
Award Group [Axis]
Award Group [Axis]
Award Group [Axis]
Disposal Group Name [Domain]
Disposal Group Name [Domain]
Percentage of principal subject to redemption
Debt Instrument, Percentage Of Principal Subject To Redemption
Debt Instrument, Percentage Of Principal Subject To Redemption
Accumulated Other Comprehensive Income Loss [Line Items]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Gross Amounts of Recognized Assets/ Liabilities
Derivative Asset, Subject to Master Netting Arrangement, before Offset
Foreign currency translation adjustments
Loss reclassified from accumulated other comprehensive income (loss) to foreign exchange loss, net of tax
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent
Class of Stock [Domain]
Class of Stock [Domain]
Customer [Domain]
Customer [Domain]
Components of Inventories
Schedule of Inventory, Current [Table Text Block]
Shares Subject to Outstanding Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues from External Customers and Long-Lived Assets [Line Items]
Income Taxes - Components of Income Before Income Tax Provision (Benefit) [Line Items]
Income Taxes - Components of Income Before Income Tax Provision (Benefit) [Line Items]
Income Taxes - Components of Income Before Income Tax Provision (Benefit)
Present value of lease liabilities
Operating Lease, Liability
Cash paid for amounts included in the measurement of lease liabilities:
Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]
Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]
Defitelio/defibrotide
Defitelio/Defibrotide [Member]
Defitelio/Defibrotide [Member]
Total Shareholder Return Vs Peer Group
Total Shareholder Return Vs Peer Group [Text Block]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Inventory
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Accumulated Other Comprehensive Loss
Total Accumulated Other Comprehensive Loss
AOCI Attributable to Parent [Member]
Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Amount
Additions charged to costs and expenses
SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
Expenses related to defined contribution plans
Defined Contribution Plan, Cost
All Executive Categories
All Executive Categories [Member]
Other
Other Products [Member]
Other Products [Member]
Net Amount
Derivative Liability, Including Not Subject to Master Netting Arrangement, after Offset and Deduction
Other
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Accumulated Other Comprehensive Income Loss [Table]
Accumulated Other Comprehensive Income (Loss) [Table]
Accrued facilities expenses
Accrued Facilities Expenses, Current
Accrued Facilities Expenses, Current
Plan Name [Axis]
Plan Name [Axis]
Accrued Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Operating lease assets
Increase (Decrease) In Operating Lease Assets
Increase (Decrease) In Operating Lease Assets
Shares authorized for issuance under deferred compensation plan (in shares)
Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance
Debt Disclosure [Abstract]
Debt Disclosure [Abstract]
Derivative Financial Instruments
Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Security Not Offset
Income tax benefit from share-based compensation expense
Share-Based Payment Arrangement, Expense, Tax Benefit
Earnings Per Share [Abstract]
Earnings Per Share [Abstract]
Net proceeds from issuance of Senior Secured Notes, due 2029
Proceeds from Issuance of Senior Long-Term Debt
Ordinary shares, nominal value $0.0001 per share; 300,000 shares authorized; 62,255 and 63,214 shares issued and outstanding at December 31, 2023 and 2022, respectively
Common Stock, Value, Issued
Redemption price, percentage
Debt Instrument, Redemption Price, Percentage
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Retirement Plan Sponsor Location [Domain]
Retirement Plan Sponsor Location [Domain]
Deferred, exclusive of other components below
Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]
Total Long-lived Assets by Location
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]
Financing cash outflows from finance leases
Finance Lease, Principal Payments
Infringed patents suit, number of patents
Loss Contingency, Patents Allegedly Infringed, Number
Schedule of Finance Lease Liability Maturities
Finance Lease, Liability, to be Paid, Maturity [Table Text Block]
Axsome
Axsome [Member]
Axsome
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Abstract]
All Individuals
All Individuals [Member]
Litigation Case [Domain]
Litigation Case [Domain]
Finance lease, right-of-use asset, statement of financial position [Extensible Enumeration]
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]
Entity Filer Category
Entity Filer Category
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Total Compensation Amount
Statement [Table]
Statement [Table]
Current Fiscal Year End Date
Current Fiscal Year End Date
Achievement target, percentage of awards granted
Share-based Compensation Arrangement by Share-based Payment Award, Achievement Target, Percentage Of Awards Granted
Share-based Compensation Arrangement by Share-based Payment Award, Achievement Target, Percentage Of Awards Granted
Disposal Group, Held-for-sale, Not Discontinued Operations
Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]
Increases recognized through purchase accounting
Unrecognized Tax Benefits, Increase Resulting from Acquisition
Total amount authorized for repurchase of shares under share repurchase program
Stock Repurchase Program, Authorized Amount
Reconciliation of Income Taxes at the Statutory Income Tax Rate to Effective Income Tax Rate
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
Schedule of Gains (Losses) on Derivative Instruments
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Balance at the beginning of the year
Balance at the end of the year
Unrecognized Tax Benefits
Income Tax Authority [Axis]
Income Tax Authority [Axis]
PEO Name
PEO Name
Fair Value, by Balance Sheet Grouping [Table]
Fair Value, by Balance Sheet Grouping [Table]
Buildings
Building [Member]
Schedule of Gross Carrying Amount of Goodwill
Schedule of Goodwill [Table Text Block]
Tax credit carryforwards
Deferred Tax Assets, Tax Credit Carryforwards
Non-cash operating activities:
Non-cash operating activities [Abstract]
Non-cash operating activities [Abstract]
Number of days provided to delist patent
Number Of Days Provided To Delist Patent
Number Of Days Provided To Delist Patent
Share-based compensation
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost
Deductions
SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction
Other
Other Accrued Liabilities, Current
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]
SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]
Current portion of lease liabilities
Operating And Finance Lease, Liability, Current
Operating And Finance Lease, Liability, Current
Interest rate (as a percent)
Debt Instrument, Interest Rate, Stated Percentage
Sunosi
Sunosi [Member]
Sunosi [Member]
Statement of Financial Position [Abstract]
Statement of Financial Position [Abstract]
Loss on disposal of a business
Gain (Loss) on Disposition of Business
Total shareholders’ equity
Beginning balance
Ending balance
Equity, Attributable to Parent
Unrecognized tax benefits that would impact the effective tax rate
Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Schedule of Finite-Lived Intangible Assets by Major Class [Table]
Schedule of Finite-Lived Intangible Assets [Table]
Recognized tax benefits related to share options exercised
Share-Based Payment Arrangement, Exercise of Option, Tax Benefit
High-sodium oxybate AG royalty revenue
High Sodium A G Oxybate Product Royalty Revenue [Member]
High Sodium A G Oxybate Product Royalty Revenue
Non-voting euro deferred shares, outstanding (in shares)
Nonvoting Euro Deferred Shares, Shares Outstanding
Nonvoting Euro Deferred Shares, Shares Outstanding
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Expected term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Acquisition of intangible assets
Payments to Acquire Intangible Assets
Long-term Debt, Fiscal Year Maturity [Abstract]
Long-Term Debt, Fiscal Year Maturity [Abstract]
Impairment of property, plant and equipment
Tangible Asset Impairment Charges
Derivatives not designated as hedging instruments
Not Designated as Hedging Instrument [Member]
Class action lawsuits filed
Loss Contingency, New Claims Filed, Number
Hedging Designation [Domain]
Hedging Designation [Domain]
Significant Other Observable Inputs (Level 2)
Fair Value, Inputs, Level 2 [Member]
Other
Other Tax Expense (Benefit)
Finite-lived intangible asset, measurement input
Finite-Lived Intangible Asset, Measurement Input
Finite-Lived Intangible Asset, Measurement Input
Impairment, intangible asset, finite-lived, statement of income or comprehensive income [Extensible Enumeration]
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration]
Disposal Group Classification [Domain]
Disposal Group Classification [Domain]
Effective interest rate (as a percent)
Debt Instrument, Interest Rate, Effective Percentage
Total purchase consideration
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
Schedule of Foreign Exchange Gain (Loss) of Outstanding Derivatives
Derivative Instruments, Gain (Loss) [Table Text Block]
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Named Executive Officers, Footnote
Named Executive Officers, Footnote [Text Block]
Document Fiscal Period Focus
Document Fiscal Period Focus
Number of trading days
Debt Instrument, Convertible, Threshold Trading Days
Accrued liabilities
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities
Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities
Finite-lived intangible asset, useful life
Finite-Lived Intangible Asset, Useful Life
Remaining borrowing capacity
Line of Credit Facility, Remaining Borrowing Capacity
Intangible assets
Deferred Tax Assets, Intangible Assets
Deferred Tax Assets, Intangible Assets
ESPP discount rate (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date
2027
Lessee, Operating Lease, Liability, to be Paid, Year Four
Outstanding, beginning balance (in dollars per share)
Outstanding, ending balance (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based compensation
Share-Based Payment Arrangement, Noncash Expense
Noncancelable purchase commitments due within one year
Unrecorded Unconditional Purchase Obligation, Due in Next Rolling 12 Months
Foreign Tax Authorities
Foreign Tax Authority [Member]
City Area Code
City Area Code
Deferred, change in tax rates
Deferred Income Tax Expense (Benefit), Change In Tax Rate [Abstract]
Deferred Income Tax Expense (Benefit), Change In Tax Rate [Abstract]
Net Income (Loss) per Ordinary Share
Earnings Per Share [Text Block]
Product and Service [Axis]
Product and Service [Axis]
Accrued construction-in-progress
Accrued Construction-In-Progress, Current
Carrying value as of the balance sheet date of obligations incurred through that date and payable for construction-in-progress. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Document Fiscal Year Focus
Document Fiscal Year Focus
Geographical [Domain]
Geographical [Domain]
Selling and marketing accruals
Accrued Marketing Costs, Current
Loss recognized in foreign exchange loss
Gain (Loss) on Fair Value Hedges Recognized in Earnings
Net proceeds from issuance of borrowings under credit agreement
Proceeds From Issuance Of Term Loan
Proceeds From Issuance Of Term Loan
Tax expense (benefit) effect on fair value hedging activities reclassified
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
Computer software
Software and Software Development Costs [Member]
Share Repurchase Program [Domain]
Share Repurchase Program [Domain]
Organization and Description of Business
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]
Schedule of Information and Activity Related to Share Option Plans Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Exercise Price
Award Exercise Price
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Weighted-average remaining lease term (years)
Weighted Average Remaining Lease Term [Abstract]
Weighted Average Remaining Lease Term
Cash dividends declared or paid
Dividends, Common Stock, Cash
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Abstract]
Derivative liabilities
Derivative Liability [Abstract]
Long-Term Purchase Commitment [Line Items]
Long-Term Purchase Commitment [Line Items]
Acquired Developed Technologies
Acquired developed technologies
Developed Technology Rights [Member]
Schedule of Share-based Compensation Expense Related to Share Options, RSUs, PSRUs and Grants Under ESPP
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Total liabilities and shareholders’ equity
Liabilities and Equity
Amortized Cost
Debt Securities, Available-for-Sale, Amortized Cost
Other non-current assets
Other Assets, Noncurrent
Peer Group Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Ownership [Domain]
Ownership [Domain]
Operating lease assets
Operating Lease, Right-of-Use Asset
Numerator:
Numerator [Abstract]
Numerator [Abstract]
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-Term Debt Instruments [Table]
Amended and Restated 2007 Non-Employee Directors Stock Award Plan
Two Thousand Seven Non Employee Directors Stock Option Plan [Member]
Two Thousand Seven Non-Employee Directors Stock Option Plan [Member]
Equity Valuation Assumption Difference, Footnote
Equity Valuation Assumption Difference, Footnote [Text Block]
Allowance for sales discounts
Allowance For Sales Discounts [Member]
Allowance For Sales Discounts [Member]
Range of risk-free rates, maximum (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
United kingdom and united states
Current Foreign Tax Expense (Benefit)
Award Group [Domain]
Award Group [Domain]
Award Group [Domain]
Acquired in-process research and development
Payments to Acquire In Process Research and Development Other Than Through Business Combination
Payments to Acquire In Process Research and Development Other Than Through Business Combination
Tax benefit effect on fair value hedging activities
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification, Tax
Other Comprehensive Income (Loss), Fair Value Hedge, Gain (Loss), after Reclassification, Tax
Net income (loss) for dilutive net income (loss) per ordinary share
Net Income (Loss) Available to Common Stockholders, Diluted
Finance lease, liability, current, statement of financial position [Extensible Enumeration]
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Arrangement Duration
Trading Arrangement Duration
Acquired IPR&D assets
In Process Research and Development [Member]
Entity Address, City or Town
Entity Address, City or Town
Award Timing MNPI Considered
Award Timing MNPI Considered [Flag]
Inventory, Current [Table]
Inventory, Current [Table]
Total lease assets
Operating Lease And Finance Lease Right-Of Use Asset
Operating Lease And Finance Lease Right-Of Use Asset
GW Incentive Plans
GW Incentive Plans [Member]
GW Incentive Plans
Remaining amount authorized for repurchase of shares
Stock Repurchase Program, Remaining Authorized Repurchase Amount
Termination Date
Trading Arrangement Termination Date
Change in estimates
Effective Income Tax Rate Reconciliation, Change In Estimate, Amount
Effective Income Tax Rate Reconciliation, Change In Estimate, Amount
Ordinary shares, authorized (in shares)
Common Stock, Shares Authorized
Estimated Fair Value
Available-for-sale securities
Debt Securities, Available-for-Sale
Gross Unrealized Gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
2021 Credit Agreement, Dollar Term Loan
Two Thousand Twenty One Credit Agreement, Dollar Term Loan [Member]
Two Thousand Twenty One Credit Agreement, Dollar Term Loan
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Measurement Input Type [Axis]
Measurement Input Type [Axis]
Derivative [Line Items]
Derivative [Line Items]
Award Timing Disclosures [Line Items]
Tranche B-1 Dollar Term Loan
Tranche B 1 Dollar Term Loan [Member]
Tranche B 1 Dollar Term Loan
Total fair value of shares vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
GW Pharmaceuticals plc
GW Pharmaceuticals plc [Member]
GW Pharmaceuticals plc
Cash Collateral Received (Pledged)
Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash Not Offset
Exchangeable Senior Notes
Convertible Debt Securities [Member]
Infringed patents suit, other party counterclaim, number of patents requested to be delisted
Infringed Patents Suit, Other Party Counterclaim, Number Of Patents Requested To Be Delisted
Infringed Patents Suit, Other Party Counterclaim, Number Of Patents Requested To Be Delisted
Deferred charge for income taxes on intercompany profit
Deferred Charge For Taxes On Intercompany Profit
Deferred Charge For Taxes On Intercompany Profit
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Income Taxes
Income Tax, Policy [Policy Text Block]
2026
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Debt Instrument, Redemption, Period [Domain]
Debt Instrument, Redemption, Period [Domain]
Insider Trading Arrangements [Line Items]
Rylaze
Rylaze [Member]
Rylaze
Total potential collaboration payments
Total Potential Collaboration Payments
Total Potential Collaboration Payments
Aggregate intrinsic value, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Other Additions
SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment
Shares issued (in shares)
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture
Entity Registrant Name
Entity Registrant Name
Material Terms of Trading Arrangement
Material Terms of Trading Arrangement [Text Block]
Award Timing Method
Award Timing Method [Text Block]
2025
Finite-Lived Intangible Asset, Expected Amortization, Year Two
Adjustment to Compensation, Amount
Adjustment to Compensation Amount
Vyxeos
Vyxeos [Member]
Vyxeos [Member]
Cost of product sales
Cost of Sales [Member]
Auditor Name
Auditor Name
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Net Income [Text Block]
Peer Group Issuers, Footnote
Peer Group Issuers, Footnote [Text Block]
Issuance of ordinary shares in conjunction with vesting of restricted stock units
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures
Disposal Group Name [Axis]
Disposal Group Name [Axis]
Assets and Liabilities Measured at Fair Value on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Exercisable (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Cash Equivalents and Investments
Cash And Cash Equivalents And Investments, Policy [Policy Text Block]
Cash And Cash Equivalents And Investments, Policy
Entity Central Index Key
Entity Central Index Key
Liabilities:
Liabilities, Fair Value Disclosure [Abstract]
Gain (loss) recognized in foreign exchange gain (loss)
Derivative, Gain (Loss) on Derivative, Net
Total share-based compensation expense, pre-tax
Share-Based Payment Arrangement, Expense
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated [Flag]
Upfront and milestone payment values
Gross Carrying Amount
Finite-Lived Intangible Assets, Gross
Finished goods
Inventory, Finished Goods, Net of Reserves
Accounts receivable
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables
Income Tax Authority [Domain]
Income Tax Authority [Domain]
Other
Deferred Other Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate
Deferred Other Income Tax Expense (Benefit), Increase (Decrease) In Tax Rate
Name
Trading Arrangement, Individual Name
Other comprehensive income (loss)
Other comprehensive (loss) income
Other comprehensive income, net
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Summary of Disaggregation of Revenue
Disaggregation of Revenue [Table Text Block]
Foreign income tax rate differential
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount
Total revenues
Revenue from Contract with Customer, Excluding Assessed Tax
Entity [Domain]
Entity [Domain]
Long-term Debt, Type [Axis]
Long-Term Debt, Type [Axis]
Amendment Flag
Amendment Flag
Legal Entity [Axis]
Legal Entity [Axis]
Gross Amounts Offset in the Consolidated Balance Sheet
Derivative Liability, Subject to Master Netting Arrangement, Asset Offset
If-converted value in excess of principal
Debt Instrument, Convertible, If-converted Value in Excess of Principal
Operating leases
Operating Lease, Weighted Average Discount Rate, Percent
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Cash paid for interest
Interest Paid, Excluding Capitalized Interest, Operating Activities
Debt Instrument, Redemption, Period Four
Debt Instrument, Redemption, Period Four [Member]
Assets:
Assets, Fair Value Disclosure [Abstract]
Increase in shares authorized for issuance under deferred compensation plan (in shares)
Deferred Compensation Arrangement With Individual, Increase In Shares Authorized For Issuance
Deferred Compensation Arrangement With Individual, Increase In Shares Authorized For Issuance
Business Acquisitions
Business Combinations Policy [Policy Text Block]
Contingent Consideration Type [Domain]
Contingent Consideration Type [Domain]
Long-term debt, less current portion
Total long-term debt
Long-Term Debt, Excluding Current Maturities
Finance leases
Finance Lease, Weighted Average Remaining Lease Term
Finance lease, liability, noncurrent, statement of financial position [Extensible Enumeration]
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]
Leasehold improvements
Leasehold Improvements [Member]
Net deferred tax liabilities
Deferred Tax Liabilities, Net
Weighted-average ordinary shares used in per share calculations - diluted (in shares)
Weighted-average ordinary shares used in per share calculations - diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Forgone Recovery, Explanation of Impracticability
Forgone Recovery, Explanation of Impracticability [Text Block]
November 2016 Share Repurchase Program
November 2016 Share Repurchase Program [Member]
November 2016 Share Repurchase Program [Member]
Derivative assets
Derivative Asset [Abstract]
Income Tax Authority, Name [Axis]
Income Tax Authority, Name [Axis]
Interest expense, net
Interest Income (Expense), Nonoperating, Net
Operating expenses:
Operating Expenses [Abstract]
Purchases of property, plant and equipment
Payments to Acquire Property, Plant, and Equipment
Company Selected Measure Amount
Company Selected Measure Amount
Options expired (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Lease Cost
Lease, Cost [Abstract]
Total assets
Assets
Name
Awards Close in Time to MNPI Disclosures, Individual Name
Share Repurchase Program [Axis]
Share Repurchase Program [Axis]
Liability Derivatives
Derivative Liability, Fair Value, Gross Liability Including Not Subject to Master Netting Arrangement
Thereafter
Finance Lease, Liability, to be Paid, after Year Five
Royalties and contract revenues
Product And Services, Royalties And Contract Revenue [Member]
Product And Services, Royalties And Contract Revenue [Member]
Weighted-average remaining contractual term, vested and expected to vest, exercisable (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term
Share-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
2028
Long-Term Debt, Maturity, Year Five
2007 Employee Stock Purchase Plan
Two Thousand Seven Employee Stock Purchase Plan [Member]
Two Thousand Seven Employee Stock Purchase Plan [Member]
Operating cash outflows from finance leases
Finance Lease, Interest Payment on Liability
Weighted-average grant-date fair value, RSUs and PRSUs released (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Non-NEOs
Non-NEOs [Member]
Jazz Securities Designated Activity Company
Jazz Securities Designated Activity Company [Member]
Jazz Securities Designated Activity Company
Construction-in-progress
Construction in Progress [Member]
McKesson
McKesson Corporation [Member]
McKesson Corporation [Member]
Prime Rate
Prime Rate [Member]
Financing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Income (loss) before income tax expense (benefit) and equity in loss of investees
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
Tax benefit effect on fair value hedging activities
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, after Reclassification Adjustment, Tax
Non-PEO NEO
Non-PEO NEO [Member]
Adjustment to Compensation:
Adjustment to Compensation [Axis]
Operating lease liabilities, less current portion
Increase (Decrease) In Operating Lease Liabilities, Noncurrent
Increase (Decrease) In Operating Lease Liabilities, Noncurrent
Total equity consideration
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
Gross Amounts Offset in the Consolidated Balance Sheet
Derivative Asset, Subject to Master Netting Arrangement, Liability Offset
Operating loss carryforwards
Deferred Tax Assets, Operating Loss Carryforwards
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Scenario [Axis]
Scenario [Axis]
Weighted-average ordinary shares used in per share calculations - basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Unamortized - debt issuance costs
Unamortized Debt Issuance Expense
Nominal Strike Price Options
Nominal Strike Price Options [Member]
Nominal Strike Price Options
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
Debt Instrument, Redemption, Period Two
Debt Instrument, Redemption, Period Two [Member]
Revenues:
Revenues [Abstract]
Aggregate intrinsic value, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested
Proceeds from employee equity incentive and purchase plans
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised
Pay vs Performance Disclosure
Pay vs Performance Disclosure [Table]
Statement [Line Items]
Statement [Line Items]
Concentration Risk [Table]
Concentration Risk [Table]
Unrecognized tax benefits, accrued interest
Unrecognized Tax Benefits, Interest on Income Taxes Accrued
Foreign derived intangible income benefit
Effective Income Tax Rate Reconciliation, FDII, Amount
Vested and expected to vest (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Quarterly amortization rate, percentage
Debt Instrument, Quarterly Amortization Rate, Percentage
Debt Instrument, Quarterly Amortization Rate, Percentage
Intangible assets
Deferred Tax Liabilities, Intangible Assets
Accounting Standards Update 2020-06 [Member]